Titre : Acétylcystéine

Acétylcystéine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Recovery of Function
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acétylcystéine : Questions médicales les plus fréquentes", "headline": "Acétylcystéine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acétylcystéine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-13", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acétylcystéine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cystéine", "url": "https://questionsmedicales.fr/mesh/D003545", "about": { "@type": "MedicalCondition", "name": "Cystéine", "code": { "@type": "MedicalCode", "code": "D003545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.125.166.230" } } }, "about": { "@type": "MedicalCondition", "name": "Acétylcystéine", "alternateName": "Acetylcysteine", "code": { "@type": "MedicalCode", "code": "D000111", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "David L Morris", "url": "https://questionsmedicales.fr/author/David%20L%20Morris", "affiliation": { "@type": "Organization", "name": "St George and Sutherland Clinical School, University of New South Wales Kogarah, Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Sarah J Valle", "url": "https://questionsmedicales.fr/author/Sarah%20J%20Valle", "affiliation": { "@type": "Organization", "name": "Mucpharm Pty Ltd, Kogarah Sydney, NSW, Australia." } }, { "@type": "Person", "name": "Krishna Pillai", "url": "https://questionsmedicales.fr/author/Krishna%20Pillai", "affiliation": { "@type": "Organization", "name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia." } }, { "@type": "Person", "name": "Samina Badar", "url": "https://questionsmedicales.fr/author/Samina%20Badar", "affiliation": { "@type": "Organization", "name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia." } }, { "@type": "Person", "name": "Javed Akhter", "url": "https://questionsmedicales.fr/author/Javed%20Akhter", "affiliation": { "@type": "Organization", "name": "Department of Surgery, St. George Hospital Sydney, NSW 2217, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Application Effectiveness of Segment IV Portal Vein Reconstruction for Early Postoperative Liver Function Recovery in Split Liver Transplantation.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37181788", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/ti.2023.10808" } }, { "@type": "ScholarlyArticle", "name": "Super resolution imaging reconstruction reveals that gold standard methods may not correctly conclude neural/brain functional recovery.", "datePublished": "2023-02-14", "url": "https://questionsmedicales.fr/article/36805708", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compmedimag.2023.102198" } }, { "@type": "ScholarlyArticle", "name": "Application of a novel nested ensemble algorithm in predicting motor function recovery in patients with traumatic cervical spinal cord injury.", "datePublished": "2024-07-29", "url": "https://questionsmedicales.fr/article/39075134", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-65755-1" } }, { "@type": "ScholarlyArticle", "name": "Zinc regulates a specific subpopulation of VEGFA + microglia to improve the hypoxic microenvironment for functional recovery after spinal cord injury.", "datePublished": "2023-10-24", "url": "https://questionsmedicales.fr/article/37883817", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2023.111092" } }, { "@type": "ScholarlyArticle", "name": "Mesencephalic astrocyte-derived neurotrophic factor promotes axonal regeneration and the motor function recovery after sciatic nerve injury.", "datePublished": "2023-06-17", "url": "https://questionsmedicales.fr/article/37393642", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bbrc.2023.06.056" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Acides aminés", "item": "https://questionsmedicales.fr/mesh/D000596" }, { "@type": "ListItem", "position": 4, "name": "Acides aminés soufrés", "item": "https://questionsmedicales.fr/mesh/D000603" }, { "@type": "ListItem", "position": 5, "name": "Cystéine", "item": "https://questionsmedicales.fr/mesh/D003545" }, { "@type": "ListItem", "position": 6, "name": "Acétylcystéine", "item": "https://questionsmedicales.fr/mesh/D000111" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acétylcystéine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acétylcystéine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acétylcystéine", "description": "Comment l'acétylcystéine est-elle utilisée dans le diagnostic ?\nQuels tests peuvent nécessiter l'acétylcystéine ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=8#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acétylcystéine", "description": "Quels symptômes l'acétylcystéine aide-t-elle à soulager ?\nQuels effets secondaires peuvent survenir ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=8#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acétylcystéine", "description": "L'acétylcystéine peut-elle prévenir des complications ?\nComment l'acétylcystéine aide-t-elle en prévention ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=8#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acétylcystéine", "description": "Dans quels cas l'acétylcystéine est-elle prescrite ?\nComment l'acétylcystéine est-elle administrée ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=8#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acétylcystéine", "description": "Quelles complications peuvent survenir avec l'acétylcystéine ?\nL'acétylcystéine peut-elle interagir avec d'autres médicaments ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=8#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acétylcystéine", "description": "Qui devrait éviter l'acétylcystéine ?\nQuels facteurs augmentent le risque d'effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D000111?mesh_terms=Recovery+of+Function&page=8#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment l'acétylcystéine est-elle utilisée dans le diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle aide à évaluer la fonction pulmonaire en fluidifiant les sécrétions bronchiques." } }, { "@type": "Question", "name": "Quels tests peuvent nécessiter l'acétylcystéine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire peuvent être réalisés pour évaluer l'efficacité du traitement." } }, { "@type": "Question", "name": "Quels symptômes l'acétylcystéine aide-t-elle à soulager ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elle soulage la toux et les difficultés respiratoires dues à des sécrétions épaisses." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des nausées, vomissements ou éruptions cutanées peuvent se produire chez certains patients." } }, { "@type": "Question", "name": "L'acétylcystéine peut-elle prévenir des complications ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut prévenir des lésions hépatiques en cas d'intoxication au paracétamol." } }, { "@type": "Question", "name": "Comment l'acétylcystéine aide-t-elle en prévention ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Elle réduit la viscosité des sécrétions, facilitant leur élimination et prévenant les infections." } }, { "@type": "Question", "name": "Dans quels cas l'acétylcystéine est-elle prescrite ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle est prescrite pour traiter les maladies respiratoires et les overdoses de paracétamol." } }, { "@type": "Question", "name": "Comment l'acétylcystéine est-elle administrée ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être administrée par voie orale ou intraveineuse, selon la situation clinique." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'acétylcystéine ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques graves, bien que rares, peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "L'acétylcystéine peut-elle interagir avec d'autres médicaments ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut interagir avec certains antibiotiques et médicaments anticoagulants." } }, { "@type": "Question", "name": "Qui devrait éviter l'acétylcystéine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques à l'acétylcystéine ou ayant des antécédents d'asthme sévère." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'effets secondaires ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'allergies et les maladies respiratoires chroniques peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Zinc regulates a specific subpopulation of VEGFA + microglia to improve the hypoxic microenvironment for functional recovery after spinal cord injury.

Spinal cord injury (SCI) is a central nervous system injury that is primarily traumatic and manifests as autonomic dysfunction below the level of injury. Our previous studies have found that zinc ions... We investigated the effect of zinc ions after spinal cord injury from the perspective of a hypoxic microenvironment, and elucidated the role of VEGF-A secreted by microglia for vascular regeneration a... Zinc promotes functional recovery after spinal cord injury by regulating VEGF-A secretion from microglia. On the one hand, VEGF-A secreted by microglia promotes angiogenesis through the PI3K/AKT/Bcl-2... Zinc promoted microglia secretion of VEGF-A, increased vascular endothelial cell proliferation and migration through the PI3K/AKT/Bcl-2 pathway, and inhibited microglia apoptosis....

Effect of Pelvic Floor Workout on Pelvic Floor Muscle Function Recovery of Postpartum Women: Protocol for a Randomized Controlled Trial.

There is a risk of pelvic floor dysfunction (PFD) from baby delivery. Many clinical guidelines recommend pelvic floor muscle training (PFMT) as the conservative treatment for PFD because pelvic floor ... The randomized controlled trial was projected to be conducted from November 2021 to March 2023. A total of 260 postpartum women would be recruited from the obstetrics departments of the study hospital... This trial will demonstrate that pelvic floor-care is accessible to most women and clinical practice on PFD may change relevantly should this study find that Online PEFLOW approach is effective to imp... ClinicalTrials.gov, NCT05218239....

Bacillus coagulans TBC169 probiotics for the recovery of intestinal function after gynecological laparoscopic surgery: a randomized, placebo-controlled trial.

Evidence suggests that Bacillus coagulans TBC169 can improve intestinal motility.... To investigate the effectiveness and safety of Bacillus coagulans TBC169 probiotics in promoting the recovery of intestinal function after gynecological laparoscopic surgery.... Patients who underwent laparoscopic surgeries due to gynecological diseases were randomly assigned to the high-dose, conventional-dose, and the placebo-control groups (1:1:1 ratio). The primary outcom... Compared to the placebo-control group, shorter FFT values were observed in the conventional-dose (23.15 h vs. 29.10 h, P < 0.05) and high-dose (19.15 h vs. 29.10 h, P < 0.001) groups. Similar trends w... Bacillus coagulans TBC169 probiotics can accelerate intestinal function recovery, and reduce postoperative adverse events in patients after gynecological laparoscopic surgery. The study protocol was r...

Urine Macrophages Polarization Predicts Renal Function Recovery after Nephron-Sparing Surgery in Patients with Renal Cell Carcinoma.

This study was conducted to investigate the underlying associations between urine macrophages polarization and renal function recovery after nephron-sparing surgery (NSS) in patients with renal cell c... Sixty-two patients with unilateral RCC who underwent NSS in our departments were prospectively recorded and followed up for long-term renal function to assess the onset of acute kidney injury (AKI) an... The cumulative incidence of postoperative AKI was 27.4% (17/62), and 47.0% (8/17) of those eventually developed to CKD during the follow-up. The mean urine M1/M2 ratio was 10.54 ± 8.13 in the AKI grou... Urine macrophages polarization could predict renal function recovery after NSS in patients with RCC. The urine M1/M2 ratio might a potential biomarker of RIRI but needs to be further verified in clini...

The effects of rehabilitation therapy duration on functional recovery of patients with subacute stroke stratified by individual's age: a retrospective multicenter study.

The duration of rehabilitation therapy is one of the key elements for promoting post-stroke functional recovery. However, whether an individual's age affects the effectiveness of the duration of rehab... This study aimed to investigate whether age has an influence on the relationship between the duration of rehabilitation therapy and post-stroke functional recovery.... This is a retrospective observational study.... Six convalescent inpatient rehabilitation hospitals in Japan.... The population of the study was represented by a total of 1186 participants with subacute stroke.... Participants were stratified into four groups according to their age (≤59, 60-69, 70-79, and ≥80 years). The data of minutes involved in performing rehabilitation therapy for participants during hospi... The mean FIM gains in the ≤59 years, 60-69 years, 70-79 years, and the ≥80 years groups were 38.7 (18.8), 32.8 (18.0), 29.7 (16.6), and 25.4 (17.2), respectively. The results of the multivariate regre... For patients with subacute stroke in rehabilitation hospitals, a higher duration of daily rehabilitation therapy was associated with better functional recovery in the 70-79 years group and ≥80 years g... An increased duration of daily rehabilitation therapy may be helpful in older adults with stroke selected for intensive rehabilitation for improvement of basic daily functioning....